Twist Bioscience Overview
Twist Bioscience Target Price
Analysts' average 12-month price target for Twist Bioscience is $90.
Get informed when a big investor buys or sells
+ FollowShare Price
$125.21
Average Target Price
$90.13
28% downside
28% downside16 analysts in the last 4 months
High: $120 | Low: $55
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-08-05 | Piper Sandler | $115 | 8.2% downside |  |
| 2026-08-04 | Robert W. Baird | $115 | 8.2% downside | |
| 2026-07-16 | Leerink PartnersPuneet Souda | $110 | 12.1% downside | |
| 2026-07-14 | Canaccord GenuityKyle Mikson | $120 | 4.2% downside | |
| 2026-07-06 | Evercore ISI | $102 | 18.5% downside | |
| 2026-06-29 | Guggenheim | $107 | 14.5% downside | |
| 2026-06-24 | BarclaysLuke Sergott | $95 | 24.1% downside | |
| 2026-06-15 | Cowen & Co. | $89 | 28.9% downside | |
| 2026-06-15 | Canaccord Genuity | $90 | 28.1% downside | |
| 2026-06-15 | UBS | $89 | 28.9% downside | |
| 2026-06-11 | Piper SandlerDavid Westenberg | $85 | 32.1% downside | |
| 2026-05-22 | Leerink PartnersPuneet Souda | $80 | 36.1% downside | |
| 2026-05-05 | GuggenheimSubbu Nambi | $60 | 52.1% downside | |
| 2026-05-05 | Robert W. BairdCatherine Ramsey Schulte | $65 | 48.1% downside | |
| 2026-05-04 | Barclays | $65 | 48.1% downside | |
| 2026-04-14 | BarclaysLuke Sergott | $55 | 56.1% downside | |
| 2026-02-03 | Robert W. Baird | $50 | 60.1% downside | |
| 2026-02-03 | Evercore ISI | $52 | 58.5% downside | |
| 2026-02-03 | Barclays | $50 | 60.1% downside | |
| 2026-01-05 | Evercore ISI | $42 | 66.5% downside | |
| 2025-12-15 | Barclays | $39 | 68.9% downside | |
| 2025-11-03 | StephensSteven Etoch | $41 | 67.3% downside | |
| 2025-10-02 | Barclays | $40 | 68.1% downside | |
| 2025-08-04 | Evercore ISI | $46 | 63.3% downside | |
| 2025-05-06 | Robert W. BairdCatherine Ramsey Schulte | $44 | 64.9% downside | |
| 2025-03-28 | Guggenheim | $50 | 60.1% downside | |
| 2025-02-04 | Robert W. BairdCatherine Ramsey Schulte | $54 | 56.9% downside | |
| 2025-02-03 | BarclaysLuke Sergott | $58 | 53.7% downside | |
| 2024-09-17 | Robert W. BairdCatherine Schulte | $46 | 63.3% downside | |
| 2024-06-05 | GuggenheimSubbu Nambi | $53 | 57.7% downside | |
| 2024-05-03 | Robert W. BairdCatherine Ramsey Schulte | $40 | 68.1% downside | |
| 2024-01-17 | Goldman SachsMatthew Sykes | $45 | 64.1% downside | |
| 2023-02-05 | BarclaysLuke Sergott | $32 | 74.4% downside | |
| 2023-01-03 | Evercore ISI | $36 | 71.2% downside | |
| 2022-10-06 | BarclaysLuke Sergott | $45 | 64.1% downside | |